European financial markets returned from the extended Easter weekend to a climate of apprehension on Tuesday, opening lower as simmering worries about global trade tensions and US economic policy ...

The ZIM stock price has remained in a technical bear market, declining by over 37% from its peak in December. It was trading at $12.95 on Monday, dragging its market cap from $3.26 billion to the ...

Highlights,Several institutional firms adjusted their stakes in Johnson Outdoors Inc. during the recent quarters.,Market data indicates ongoing financial challenges, including a negative earnings ...

Highlights:,YPF Sociedad Anónima has experienced mixed ratings, with a strong presence in the oil and gas sector.,Institutional investors are actively adjusting their holdings, signaling a focus on ...

EyePoint Pharmaceuticals Gains Institutional Attention Amid Financial Challenges Highlights,EyePoint Pharmaceuticals maintains focus on treatments for retinal diseases using sustained-release drug ...

Shares of metal companies rose up to 2% on Monday, tracking gains in broader markets, after the Indian government imposed a 12% safeguard duty on certain steel imports. The decision, aimed at curbing ...

Highlights:,Cross Country Healthcare, Inc. operates in the healthcare staffing and talent management segment.,The stock is trading within a consistent range, reflecting recent market ...

Highlights:,Repligen Corporation has reported earnings surpassing earlier expectations in a recent financial period.,Multiple institutions have increased positions in the company amid industry shifts.

Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any ...

Swiss pharmaceutical giant Roche unveiled ambitious plans on Tuesday for a substantial $50 billion investment in the United States over the coming five years. This significant commitment represents ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...

A Morgan Stanley analyst has issued a major warning that may impact risky assets, including stocks and cryptocurrencies such as Ethereum, Jasmy, Cardano, Kaspa, and PEPE. His statement came as these ...